Drug profile · INN
recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell)
CERVARIX
recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell) (CERVARIX) is a biological vaccine - induces immune response.
Drug details — recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell)
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.78
Quick answer
recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell) (CERVARIX) is a biological vaccine - induces immune response.
Key facts
Mechanism of action
Biological vaccine - induces immune response
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Pipeline programs
Frequently asked questions
What is recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell)?
recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell) (CERVARIX) is a biological vaccine - induces immune response.
What is the brand name for recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell)?
CERVARIX is a marketed brand name for recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from trichoplusia ni cell). Check FDA Drugs@FDA for the current US label holder and prescribing information.